studies Archives

magic mushrooms receives breakthrough status from the fda

Psilocybin Receives Breakthrough Status by the FDA for Depression

September 1, 2020 May 16, 2022

In November 2019, the US Food and Drug Administration (FDA) granted psilocybin therapy a breakthrough status for depression. This recognition makes it the second time in a year the FDA would designate such a status to psilocybin, the hallucinogenic compound in psychedelic mushrooms. The FDA’s action is meant to fast-track the typical slow process of […]

About Us

2. The Mind Mend™ promise is to provide the best psilocybin products and superior customer support with research-backed education

Quick Links

Connect with us

English

French

* DISCLAIMER: You must be 19 years of age to use this site. The contents of this site are for informational purposes only. The statements made on this site have not been evaluated by the Food and Drug Administration (FDA). The efficacy of psilocybin mushroom products has not been confirmed by FDA-approved research. Psilocybin mushroom products are not intended to diagnose, treat, cure or prevent any disease. The content of this site is not intended to be a substitute for professional medical advice, counselling, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this site. You are responsible to know and adhere to your Province’s laws and regulations regarding psilocybin mushroom use as related activities all of which remain illegal under federal law.